Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Sensitive Oligometastatic Prostate Cancer”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Early research (Phase 1)Active Not RecruitingNCT06229366
What this trial is testing

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerOligometastatic Prostate Carcinoma+1 more
Eli Lilly and Company 142
Not applicableWithdrawnNCT05245435
What this trial is testing

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna
Testing effectiveness (Phase 2)Active Not RecruitingNCT03795207
What this trial is testing

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Who this might be right for
Node; ProstateBone MetastasesProstate Cancer Patients
Institut Cancerologie de l'Ouest 96
Not applicableWithdrawnNCT03301701
What this trial is testing

Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Hormone Sensitive Oligometastatic Prostate Cancer
Dr. Patrick Cheung
Testing effectiveness (Phase 2)Active Not RecruitingNCT03361735
What this trial is testing

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
City of Hope Medical Center 25
Testing effectiveness (Phase 2)UnknownNCT05717660
What this trial is testing

APalutamiAPalutamide and stEReotactic Body Radiation Therapy for Metastatic Prostate Cancer

Who this might be right for
Oligometastatic Hormone Sensitive Prostate Cancer
Azienda Ospedaliero-Universitaria Careggi 180
Early research (Phase 1)Looking for participantsNCT07824349
What this trial is testing

JUR-003 in Adult Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate CancerOligometastatic Prostate Cancer (OMPC)Metastatic Hormone Sensitive Prostate Cancer
Juri Biosciences, Inc. 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544830
What this trial is testing

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
PSA Level Greater Than TwoStage IV Prostate Adenocarcinoma AJCC v7
City of Hope Medical Center 29
Early research (Phase 1)Active Not RecruitingNCT05079698
What this trial is testing

Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Looking for participantsNCT05915442
What this trial is testing

Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
Catherine Spina 23
Large-scale testing (Phase 3)Looking for participantsNCT05352178
What this trial is testing

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven 873
Not applicableActive Not RecruitingNCT07766486
What this trial is testing

Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation Therapy

Who this might be right for
Oligometastatic Hormone-Sensitive Prostate CancerProstate Adenocarcinoma
Fondazione del Piemonte per l'Oncologia 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04619069
What this trial is testing

Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04115007
What this trial is testing

Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients

Who this might be right for
Oligometastatic Hormone Sensitive Prostate Cancer
UNICANCER 550
Not applicableLooking for participantsNCT04983095
What this trial is testing

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticRadiation TherapyPositron-Emission Tomography
Karin Soderkvist 118
Not applicableActive Not RecruitingNCT03784755
What this trial is testing

Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Canadian Cancer Trials Group 409
Testing effectiveness (Phase 2)UnknownNCT04641078
What this trial is testing

Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+2 more
University Hospital, Ghent 124